重编程
血管生成
利基
癌症研究
新生血管
再生医学
医学
生物
生物信息学
细胞生物学
干细胞
遗传学
细胞
生物化学
作者
Gaël Cagnone,Sheetal Pundir,Charlotte Betus,Tapan Agnihotri,Anli Ren,Jin Sung Kim,Noémie-Rose Harvey,Émilie Heckel,Mei Xi Chen,Anu Situ,Perrine Gaub,Nicholas Kim,Ashim Das,Séverine Leclerc,Florian Wünnemann,Louis Berillon,Grégor Andelfinger,Sergio Crespo‐Garcia,Alexandre Dubrac,Flávio Rezende
标识
DOI:10.1038/s41467-025-60061-4
摘要
ABSTRACT Healthy blood vessels supply neurons to preserve metabolic function. In blinding ischemic proliferative retinopathies (PRs), pathological neovascular tufts often emerge in lieu of needed physiological neuroretina revascularization. We show that metabolic shifts in the neurovascular niche define this angiogenic dichotomy between healthy and diseased blood vessel growth. Fatty acid oxidation (FAO) metabolites accumulated in human and murine retinopathy samples. Neovascular tufts with a distinct single-cell transcriptional signature highly expressed FAO enzymes. The deletion of Sirt3 , an FAO regulator, shifted the neurovascular niche metabolism from FAO to glycolysis and suppressed tuft formation. This metabolic transition increased Vegf expression in astrocytes and reprogrammed pathological EC to a physiological phenotype, hastening vascular regeneration of the ischemic retina. Our findings identify SIRT3 as a metabolic switch in the neurovascular niche, offering a new therapeutic target for optimizing ischemic tissue revascularization. Highlights Pathological EC favor FAO over glycolysis. Unique signature for pathological EC found in proliferative retinopathy model. Sirt3 deletion shifts astrocytes and EC metabolism from FAO to glycolysis. Metabolic reprogramming of the vascular niche enhances physiological revascularization. Graphical Abstract
科研通智能强力驱动
Strongly Powered by AbleSci AI